November 16th, 2024
This conference has already taken place.
Description
Welcome to the Annual Neurogastroenterology and Motility Conference , a premier event designed to enrich the knowledge and skills of primary care doctors, GI doctors, nurses, advanced practice providers (APPs), medical students, and residents. This comprehensive conference offers a deep dive into the latest advancements in the pathophysiology, diagnosis, and management of gastrointestinal (GI) motility disorders.
Stations:
Station 1: Esophageal Manometry
Station 2: Bravo, 24-Hour pH Monitoring
Station 3: EndoFLIP/EsoFLIP
Station 4: Anorectal Manometry
Benefits for Participants:
Enhanced Knowledge: Stay at the forefront of GI motility disorder management with updates on pathophysiology, diagnostic techniques, and treatment options.
Practical Skills: Gain hands-on experience with key diagnostic tools and procedures, enhancing your clinical capabilities.
Networking Opportunities: Connect with peers, experts, and researchers in the field, fostering collaboration and professional growth.
Comprehensive Learning: A well-rounded agenda covering a wide range of GI motility disorders, ensuring participants leave with a holistic understanding of the subject.
Join us at the OSU GI Motility Conference 2024 to advance your practice, improve patient outcomes, and collaborate with leading experts in the field. We look forward to your participation and to a stimulating and educational experience.
For pricing information, see pricing tab below.
Dates and Times
Start: 11/16/2024 8:00 AM
End: 11/16/2024 3:00 PM
Objectives
1. After attending the keynote address and presentations on IBS, participants will be able to:
• Describe the latest updates in the pathophysiology of irritable bowel syndrome (IBS) without using subjective terms.
• Identify evidence-based management strategies for IBS that can be applied in clinical practice.
• Discuss the significance of advancements in IBS management in improving patient health outcomes.
2. Following the session on pelvic floor dysfunction, learners will be able to:
• Explain the diagnostic strategies used in identifying pelvic floor dysfunction in patients.
• Outline evolving treatment approaches for pelvic floor dysfunction, emphasizing evidence-based practices.
• Describe the potential impact of improved management of pelvic floor dysfunction on patient health and quality of life.
3. After the discussion on the surgeon’s role in chronic constipation and fecal incontinence, participants will be able to:
• Identify the role of surgeons in the management of chronic constipation and fecal incontinence.
• Discuss patient selection criteria for surgical interventions in chronic constipation and fecal incontinence.
• Explain how appropriate surgical approaches can positively impact patient health outcomes.
4. Following the session on evaluation and management of refractory reflux, participants will be able to:
• Explain the mechanisms underlying refractory reflux and its management.
• Describe diagnostic methods for evaluating refractory reflux without using subjective terms.
• Discuss evidence-based approaches to managing refractory reflux and their potential impact on patient health outcomes.
5. After the discussion on diagnosis and management of cyclic vomiting, learners will be able to:
• Identify diagnostic criteria for cyclic vomiting syndrome (CVS) based on objective measures.
• Discuss evidence-based management strategies for CVS that can improve patient outcomes.
• Explain the importance of timely diagnosis and management of cyclic vomiting in enhancing patient health and well-being.
6. Following the hands-on sessions on esophageal manometry, Bravo pH monitoring, EndoFLIP/EsoFLIP, and anorectal manometry, participants will be able to:
• Perform and interpret diagnostic tests related to GI motility disorders competently.
• Demonstrate proficiency in using various diagnostic tools and techniques accurately.
• Discuss the clinical significance of diagnostic findings in guiding treatment decisions and improving patient health outcomes.
Pricing
| Tier | Price |
|---|---|
| Health Care Professionals | $25.00 |
| Students | $0.00 |
Speakers
Location
James L035 (Wasserstrom Room)
460 W. 10th Ave
Columbus, OH 43210
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 4.75 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.